stockrow
Friday 6 November 2026
Export AMTX’s income statement to Excel — free account
Aemetis, Inc
AMTX Basic Materials Specialty Chemicals
Aemetis, Inc’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, down 26.2% from fiscal 2024.
- Revenue
- +48.9%
- EPS
- +118.9%
- Free cash flow
- +269.0%
- Total debt
- +12.6%
Quarter to September 2026, against a year earlier
1.62
0.11
−6.36%
Follow AMTX
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.52 | 0.53 | 1.02 | 0.42 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
5.88 | (61.77) | (20.19) | 14.44 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.01 | 2.19 | 2.69 | 2.13 | |
EV/EBITDA |
134.26 | 128.83 | 0.00 | 0.00 | |
EV/Operating CF |
32.75 | (133.48) | (75.69) | 129.18 | |
EV/FCF |
(13.69) | (12.21) | (14.78) | (18.54) | |
Quick Ratio |
0.01 | 0.04 | 0.03 | 0.03 | |
Current Ratio |
0.07 | 0.08 | 0.09 | 0.07 | |
Net Debt/EBITDA |
0.00 | 41.99 | (191.95) | 169.50 | |
Debt/Assets |
120.18% | 126.27% | 131.65% | 132.02% | |
Debt/Equity |
(1.19) | (1.13) | (1.11) | (1.12) | |
Asset Turnover |
0.90 | 0.83 | 0.82 | 0.76 | |
Operating CF/Net income |
4.21 | 0.20 | 0.49 | (1.08) | |
Capex/Depreciation |
0.00 | (2.94) | (1.45) | (3.70) | |
Interest Coverage |
1.47 | 0.43 | (0.51) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.78% | 12.35% | 16.64% | 23.57% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 1.79% | 3.21% | 1.95% | |
Graham Net Nets |
(4.63) | (4.97) | (2.61) | (6.47) | |
Graham Number |
6.77 | 9.65 | 11.35 | 12.37 | |
Earnings Yield |
(26.40%) | (55.49%) | (37.30%) | (95.68%) | |
Free Cash Flow Yield |
(28.35%) | (33.83%) | (17.92%) | (27.27%) | |
Revenue per Share |
1.22 | 0.88 | 0.82 | 0.72 | |
Operating CF per Share |
0.30 | (0.03) | (0.16) | 0.10 | |
Capex per Share |
(0.28) | (0.12) | (0.10) | (0.28) | |
Free Cash Flow per Share |
0.02 | (0.15) | (0.26) | (0.18) | |
Cash per Share |
0.05 | 0.01 | 0.07 | 0.08 | |
Shareholders Equity per Share |
(4.33) | (4.54) | (4.81) | (5.12) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(4.33) | (4.54) | (4.81) | (5.12) | |
Free Cash Flow |
1.73 | (10.42) | (17.10) | (10.79) | |
Working Capital |
(410.70) | (382.03) | (361.56) | (344.39) | |
Capital Expenditures |
(20.22) | (8.53) | (6.55) | (16.56) | |
Net Current Asset Value |
(597.07) | (578.29) | (556.78) | (539.80) | |
EV/EBIT |
28.11 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.23 | 0.14 | 0.12 | 0.38 | |
Price to Operating Income |
7.25 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 8.59 | 3.81 | 10.03 | |
Average Payables |
33.26 | 26.59 | 27.92 | 28.28 | |
Average Inventory |
8.85 | 13.00 | 16.66 | 18.53 | |
Average Assets |
276.56 | 264.60 | 256.42 | 259.57 | |
Average Common Equity |
(309.53) | (305.68) | (300.92) | (285.38) |
Columns are period end dates · fundamentals updated 5 Nov 2026